Populations in developed nations are aging gradually; it is predicted that by 2050 almost a quarter of the world’s population will be over 60 years old, more than twice the figure at the turn of the 20th century. Although we are living longer, this does not mean the extra years will be spent in good health. Cardiovascular diseases are the primary cause of ill health and their prevalence increases with age. Traditionally, lipid biomarkers have been utilized to stratify disease risk and predict the onset of cardiovascular events. However, recent evidence suggests that hormonal interplay with lipid metabolism could have a significant role to play in modulating cardiovascular disease risk. This review will explore recent findings which have investigated the role hormones have on the dynamics of lipid metabolism. The aim is to offer an insight into potential avenues for therapeutic intervention.
- Cardiovascular disease
- Growth hormone
- Lipid metabolism
- Stress hormone
Mc Auley, MT., & Mooney, KM. (2014). Lipid Metabolism and Hormonal Interactions: Impact on Cardiovascular Disease & Healthy Aging. Expert Review of Endocrinology and Metabolism, 9(4), 357-367. https://doi.org/10.1586/17446651.2014.921569